A naturally randomized trial evaluating the potential clinical benefit of therapies that reduce triglyceride-rich lipoproteins on the risk of coronary heart disease
Session:
Late Breaking Registry Results 2
Topic:
Drug therapy
Speaker:
Professor B. Ference (Cambridge, GB)
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Brian A Ference
University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
31
presentations
7
followers
12 more presentations in this session
Access the full session
Late Breaking Registry Results 2
Speakers:
Professor B. Ference, Professor J. Camm, Professor K. Fox
About the event
ESC 365 is supported by
